TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Mias Lymfterapi AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
103
|
126
|
83 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
41
|
50
|
17 |
| EBITDA |
40
|
50
|
17 |
| Total assets |
277
|
248
|
197 |
| Current assets |
277
|
248
|
197 |
| Current liabilities |
27
|
31
|
19 |
| Equity capital |
250
|
217
|
178 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
90.3%
|
87.5%
|
90.4% |
| Turnover per employee |
103
|
126
|
83 |
| Profit as a percentage of turnover |
39.8%
|
39.7%
|
20.5% |
| Return on assets (ROA) |
14.8%
|
20.2%
|
8.6% |
| Current ratio |
1025.9%
|
800%
|
1036.8% |
| Return on equity (ROE) |
16.4%
|
23.0%
|
9.6% |
| Change turnover |
-23
|
43
|
-11 |
| Change turnover % |
-18%
|
52%
|
-12% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.